Justin Moser

Clinical trials

• Single Arm Trial of Tumor-Treating Fields in Combination With Nivolumab and Ipilimumab in Metastatic Uveal Melanoma

  Principal investigator · Completed · Phase 1

  HonorHealth Research Institute

  2022–2025
• A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors

  Site PI · Recruiting · Phase 1, Phase 2

  VM Discovery, Inc.

  2026–2031
• Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab

  Site PI · Recruiting · Phase 1, Phase 2

  Strand Therapeutics Inc.

  2026–2030
• A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

  Site PI · Recruiting · Phase 1

  SHY Therapeutics

  2026–2028